Morphometry of medial temporal lobe subregions using high‐resolution T2‐weighted MRI in ADNI3: Why, how, and what's next? is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: U19‐AG024904
National Institute on Aging
Grant: RF1‐AG056014
National Institute on Aging
Grant: R01‐AG069474
National Institute on Aging
Grant: P30‐AG072979
National Institute on Aging
Grant: R01‐AG070592
National Institute of Neurological Disorders and Stroke
Grant: R25‐NS065745
NIA NIH HHS
Grant: R01 AG056014
NIA NIH HHS
Grant: U19-AG024904
NIA NIH HHS
Grant: R01-AG069474
NIA NIH HHS
Grant: U19 AG024904
NINDS NIH HHS
Grant: R25-NS065745
NIA NIH HHS
Grant: RF1-AG056014
NIA NIH HHS
Grant: R01-AG070592
NIA NIH HHS
Grant: RF1 AG056014
NIA NIH HHS
Grant: P30-AG072979
NINDS NIH HHS
Grant: R25 NS065745
NIA NIH HHS
Grant: R01 AG069474
NINDS NIH HHS
Grant: UE5 NS065745
The Alzheimer's Association
Grant: AACSF-23-1152241
NIA NIH HHS
Grant: P30 AG072979
NIA NIH HHS
Grant: R01 AG070592
NIA NIH HHS
Grant: RF1 AG069474
NIA NIH HHS
Grant: U01 AG024904
National Institutes of Health
Grant: 5R01AG069474-03
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's disease
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P30AG072979-02
Penn Alzheimer's Disease Research Center (ADRC)
National Institutes of Health
Grant: 5R01AG070592-02
A harmonized medial temporal lobe subregion segmentation protocol: an essential element for dementia research
National Institutes of Health
Grant: 2RF1AG056014-06
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology Associations
National Institutes of Health
Grant: 5R25NS065745-14
Research Training Program in Disease Oriented Neuroscience (R25)
National Institutes of Health
Grant: 3U19AG024904-18S3
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
Biogen
Bristol-Myers Squibb Company
Elan Pharmaceuticals, Inc.
Fred A. and Barbara M. Erb Family Foundation
Piramal Imaging
Transition Therapeutics
BioClinica
CereSpir, Inc.
Foundation for the National Institutes of Health (FNIH)
Johnson & Johnson Pharmaceutical Research & Development LLC
Lundbeck
Takeda Pharmaceutical Company
CIHR
Canadian Institutes of Health Research
Merck
National Institute of Biomedical Imaging and Bioengineering
Pfizer
AbbVie
F. Hoffmann-La Roche Ltd.
GE Healthcare
IXICO Ltd.
NeuroRx Research
Novartis Pharmaceuticals Corporation
Bristol-Myers Squibb
Cogstate
EuroImmun
F. Hoffmann-La Roche
Fujirebio
NIBIB NIH HHS
Neurotrack Technologies
Janssen Alzheimer Immunotherapy Research & Development, LLC
Merck & Co., Inc.
Pfizer Inc.
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation
BioClinica, Inc.
Eisai Inc.
Lumosity
Araclon Biotech
Eli Lilly and Company
Fujirebio Europe
H. Lundbeck A/S
Meso Scale Diagnostics
Servier
CIHR
AbbVie
Transition Therapeutics
Cogstate
Meso Scale Diagnostics
Fred A. and Barbara M. Erb Family Foundation
EuroImmun
Biogen
Alzheimer's Drug Discovery Foundation
Servier
Lumosity
Bristol-Myers Squibb Company
Piramal Imaging
Takeda Pharmaceutical Company
Araclon Biotech
Novartis Pharmaceuticals Corporation
CereSpir, Inc.
BioClinica, Inc.
GE Healthcare
NIBIB NIH HHS
Johnson & Johnson Pharmaceutical Research & Development LLC
Pfizer Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
IXICO Ltd.
NeuroRx Research
Merck & Co., Inc.
Janssen Alzheimer Immunotherapy Research & Development, LLC
Neurotrack Technologies
Foundation for the National Institutes of Health (FNIH)
Fujirebio
Lundbeck
Eisai Inc.
FWCI
4.28
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords